Related Experiment Video
Updated: Feb 12, 2026

Methodology for Accurate Detection of Mitochondrial DNA Methylation
Published on: May 20, 2018
Berberine C9-Derivatives Selective Cytotoxicity Depends on Balance Between Mitochondrial Damage and DNA Intercalation
Anastasiia Yu Kolchanova1, Konstantin G Lyamzaev1, Nicolae Valutsa2
1Chemistry Department and AN Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation.
Abstract:
Berberine, a naturally occurring compound, inhibits the growth of cancer cells in vitro at micromolar concentrations. Selective cytotoxicity was revealed for berberine derivatives and monoterpene aminoalcohols in the FCCT (fluorescent cells co-cultivation test) screening of almost a 100 recently synthesized compounds. C9-substituted berberines were found to be selective and cytotoxic in the nanomolar concentration range, and were investigated in detail. They exhibit some selectivity for A549 and MCF7 cancer cells in comparison to non-cancerous VA13 cells. Several berberine derivatives were synthesized, which allowed us to analyze their structure-activity relationships (SAR) and mechanism of action on the cells. Investigation of berberine's and its derivatives' action on the cells revealed some similarities with DNA intercalators. Compounds bearing charged groups, such as 1 and 2, have also been observed to disrupt the mitochondrial membrane potential. Compound 17a, lacking a charge on the nitrogen, retains the effects on the cells and the ability to intercalate DNA, but affects mitochondria only at high concentrations. The significant mechanism of action of the investigated berberine derivatives is intercalation into DNA.
Insights
Berberine derivatives show selective cancer cell growth inhibition. The most effective compounds, C9-substituted berberines, work at nanomolar concentrations by intercalating into DNA.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Cancer Biology
Background:
- Berberine, a natural compound, exhibits anticancer properties in vitro.
- Screening of novel compounds identified berberine derivatives with selective cytotoxicity.
- C9-substituted berberines demonstrated potent activity in the nanomolar range.
Purpose of the Study:
- To synthesize and evaluate novel berberine derivatives for anticancer activity.
- To investigate the structure-activity relationships (SAR) of these derivatives.
- To elucidate the mechanism of action of potent berberine derivatives.
Main Methods:
- Fluorescent cells co-cultivation test (FCCT) for cytotoxicity screening.
- Synthesis of various berberine derivatives.
- Analysis of DNA intercalation and mitochondrial membrane potential disruption.
Main Results:
- C9-substituted berberines showed selective cytotoxicity against A549 and MCF7 cancer cells.
- Several derivatives exhibited potent anticancer activity at nanomolar concentrations.
- DNA intercalation was identified as a significant mechanism of action.
- Mitochondrial disruption was observed for charged berberine derivatives.
Conclusions:
- Berberine derivatives, particularly C9-substituted ones, are promising anticancer agents.
- DNA intercalation is a key mechanism for their cytotoxic effects.
- Further research into these compounds could lead to novel cancer therapies.
More Related Videos
Related Concept Videos
Frequency-dependent Selection
Animal Mitochondrial Genetics
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Balancing Redox Equations
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

